Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.50
Bid: 29.00
Ask: 30.00
Change: -0.50 (-1.67%)
Spread: 1.00 (3.448%)
Open: 29.50
High: 29.50
Low: 29.50
Prev. Close: 30.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update and Notice of Results

4 Dec 2019 07:00

RNS Number : 5553V
Ilika plc
04 December 2019
 

Ilika plc

("Ilika" or the "Company")

 

Trading update and Notice of Results

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, provides a trading update for the six months ended 31 October 2019, in advance of a site visit for analysts and investors that will take place tomorrow, Thursday 5 December 2019. No new material information regarding current trading will be disclosed at the site visit. All attendees must register through Walbrook PR to reserve a space. 

 

Financial Highlights

Trading in the first half of the year has been in line with our expectations and the financial results are expected to show a 50% increase in total revenue for the period to £1.5m relative to the same period last year (H1 2018: £1.0m). This increase in revenue has translated into a reduced EBITDA Loss of £1m relative to the EBITDA Loss for the same period last year (H1 2019: £1.3m). Cash and cash equivalents at the period end were £1.9m (H1 2018: £5.8m) with further receipts of £0.7m banked post period end.

 

Operating Highlights

Ilika has continued to develop and commercialise its thin-film miniature Stereax solid state batteries for powering wireless sensors, as well as progressing its large format Goliath cells for electric vehicles (EV).

 

In April 2019, Ilika launched its Stereax® M50 mm-scale solid-state batteries designed for medical implants. This product brings a unique technology option for devices requiring miniature, biocompatible batteries with a zero risk of leakage and a long life-span. At the same time, Ilika optimised its photolithographic process to be able to offer customisable battery sizes and shapes. Applications include the monitoring of heart rhythm, blood pressure, glucose levels and also provision of neurostimulation.

 

The second significant addressable market for Stereax® batteries is industrial IoT, where the hostile operating environment requires a low maintenance wireless solution, possibly combined with elevated operating temperatures. Over the last six months, Ilika has continued to execute its demonstration deployments in wind turbines, rail networks and environmental pollution monitors. It has also further improved product robustness, including demonstrating a strong performance capability during rapid temperature change.

 

In September 2019, Ilika announced its third Goliath development alliance, code-named "Granite", with Jaguar Land Rover and AGM Batteries, supported by grant funding from the UK Government's Faraday Battery Challenge. The aim of this particular project is to develop cost-effective routes for scaling-up Ilika's Goliath technology. This brings the total grant support available to Ilika for the development of Goliath to £5m.

 

In the same month, Ilika announced the opening of its new large format battery facility, the Goliath pre-pilot line. This facility underpins its portfolio of industrial collaboration programmes, including Granite, MoSESS (with McLaren and A123) and PowerDrive Line (with Honda and Ricardo).

 

Ilika's activities in the sector were recognised with a Green Economy Classification from the London Stock Exchange in October 2019.

 

Ilika expects to announce half-year results for the six months ended 31 October 2019 on 23 January 2020.

 

Graeme Purdy, CEO of Ilika, said: "Ilika's ability to act in an agile, speedy manner has been demonstrated by the short time it has taken us to design, outfit and commission our new facility for solid-state large format cells over the summer. Our continued commercial progress is a promising reflection of the large pipeline of opportunities we have for both miniature Stereax® and Goliath."

 

 

For more information contact:

 

Ilika plc

 

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Liberum Capital Limited (Nomad and Broker)

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan, William Hall

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Lianne Cawthorne

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCQXLFBKLFXFBX
Date   Source Headline
23rd Aug 20131:25 pmRNSPosting of Annual Report & Notice of AGM
2nd Aug 20135:02 pmRNSConversion of Securities
30th Jul 20137:00 amRNSContract Renewals and Grant Award
19th Jul 20132:50 pmRNSHolding(s) in Company
19th Jul 201311:17 amRNSHolding(s) in Company
18th Jul 20137:00 amRNS£3.3 million EPSRC Grant Award to Southampton Univ
15th Jul 20137:00 amRNSFinal Results
21st May 20131:09 pmRNSHolding(s) in Company
20th May 20137:00 amRNSDirectorate Change and Conversion of Securities
17th May 20133:57 pmRNSPlacing - Replacement
17th May 20137:00 amRNSPlacing
1st May 20137:00 amRNSFuel Cell Catalyst Patent Granted in Japan
22nd Apr 20137:00 amRNSContract with new European Customer
16th Apr 20137:00 amRNSTrading Update
21st Feb 20137:00 amRNSRenewal of Contract
29th Jan 20137:00 amRNSCompletion of Laboratory Facility Expansion
18th Jan 20133:28 pmRNSHolding(s) in Company
17th Jan 20135:46 pmRNSHolding(s) in Company
17th Jan 201311:16 amRNSHolding(s) in Company
15th Jan 20135:21 pmRNSHolding(s) in Company
10th Jan 20137:00 amRNSInterim Results
21st Dec 20127:00 amRNSGrant of Fuel Cell Catalyst Patent
18th Dec 20121:41 pmRNSCompletion of Disposal
17th Dec 20127:00 amRNSConversion of Securities
11th Dec 20127:00 amRNSRenewal of Contract
29th Nov 20124:44 pmRNSHolding(s) in Company
28th Nov 20125:00 pmRNSHolding(s) in Company
27th Nov 20122:18 pmRNSHolding(s) in Company
19th Nov 20127:00 amRNSEnergizer Relationship Update
22nd Oct 20127:00 amRNSTrading Update
5th Oct 20127:00 amRNSHolding(s) in Company
5th Oct 20127:00 amRNSTotal Voting Rights
18th Sep 20127:00 amRNSDiscontinuing of wound care products and services
14th Sep 20127:00 amRNSCarbon Trust Investment
7th Sep 20121:27 pmRNSResult of AGM
7th Sep 20127:00 amRNSAGM Statement
9th Aug 20127:00 amRNSPosting of Annual Report & Notice of AGM
19th Jul 20127:00 amRNSFinal Results
14th Jun 20127:14 amRNSChange of Adviser
1st Jun 201210:01 amRNSTotal Voting Rights
18th May 20127:00 amRNSTrading Update
17th May 20127:00 amRNSConversion of Securities
2nd May 20127:00 amRNSVapour Deposition Method US Patent Grant
1st May 20123:00 pmRNSHolding(s) in Company
30th Apr 201210:27 amRNSDirector's Dealings
30th Apr 201210:22 amRNSTotal Voting Rights
25th Apr 20122:02 pmRNSHolding(s) in Company
23rd Apr 20122:44 pmRNSHolding(s) in Company
23rd Apr 20128:01 amRNSDirector/PDMR Shareholding
20th Apr 201212:49 pmRNSGeneral Meeting Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.